Skip to content

Opko Health

US · OPK #3224 by market cap
1.57 -0.04 -2.48%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 1.57 -2.42%
After-hours 1.57 +0.04%
1.771.171.572026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on OPK?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +14.2% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation B

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 14.6x Better than 57%
Price / Sales 1.9x Better than 59%
Growth D

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -15.5% Better than 4%
Net income CAGR (3Y) 0.0% Better than 41%
Profitability D

How much profit the business keeps from each dollar of sales and capital.

Gross margin 33.9% Better than 39%
Operating margin -36.1% Better than 10%
Net margin -37.2% Better than 10%
Return on equity -17.1% Better than 17%
Return on invested capital -7.8% Better than 19%
Momentum A-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 6.1% Better than 85%
6-month return 23.6% Better than 86%
12-month return (ex latest month) 23.5% Better than 63%
Distance below 52-week high 15.6% Better than 70%
Financial Health C

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 4.0x Better than 81%
Debt to assets 20.5% Better than 55%
Interest coverage -1.2x Better than 21%
Free cash flow / net income 18.9% Better than 5%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 96.2% Better than 82%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -6.55%
1M -5.42%
3M +7.53%
6M +27.64%
YTD +24.60%
1Y +20.77%
3Y +6.08%
5Y -63.91%

Key statistics

Price & volume

Prev close
1.61
Open
1.57
Day range
1.55 - 1.62
Avg price
1.57
Volume
3.52M
Turnover
5.54M
Amplitude
4.66%
52-week range
0.98 - 1.86

Valuation

P/E
-5.23
P/E (TTM)
-7.85
P/B
1.04
EPS
-0.30
Net profit
-222.75M
Net assets
1.12B

Share structure

Market cap
1.17B
Float cap
502.27M
Shares out
742.51M
Float shares
319.92M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 67% of range
0.98 1.86

15.6% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-4.06M net over the window

Short interest

Shares short
32.85M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Opko Health (OPK)?

Opko Health last traded at 1.57. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Opko Health's market cap?

About 1.17B.

What is the P/E ratio of Opko Health?

The trailing twelve-month P/E is -7.85. The Valuation tab shows it against the stock's own five-year range.

Does Opko Health pay a dividend?

Opko Health does not currently pay a regular dividend.

Is Opko Health a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 3.08, which implies 96.2% upside from the current price. This is not investment advice.

What is Opko Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Opko Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:36 · For reference only, not investment advice and not tailored to your situation.

Opko Health discussion 0 comments

Add a comment